The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease
To investigate the clinical features of parenchymal neuro-Behcet’s disease (p-NBD), we retrospectively reviewed the medical records of 1009 BD patients admitted to Peking Union Medical College Hospital from 2000 to 2016. Forty-two patients (25 males and 17 females) with p-NBD and eighty-four age- an...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2019/7371458 |
id |
doaj-4f69d2fa4a57407f83c3777bf4f0b877 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Dong Yan JinJing Liu Yuehua Zhang Wei Yuan Yan Xu Jing Shi Chaoran Li Yining Wang Linyi Peng Yunjiao Yang Jiaxin Zhou Di Wu Zhichun Liu Xiaofeng Zeng Fengchun Zhang Wenjie Zheng Yan Zhao |
spellingShingle |
Dong Yan JinJing Liu Yuehua Zhang Wei Yuan Yan Xu Jing Shi Chaoran Li Yining Wang Linyi Peng Yunjiao Yang Jiaxin Zhou Di Wu Zhichun Liu Xiaofeng Zeng Fengchun Zhang Wenjie Zheng Yan Zhao The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease Journal of Immunology Research |
author_facet |
Dong Yan JinJing Liu Yuehua Zhang Wei Yuan Yan Xu Jing Shi Chaoran Li Yining Wang Linyi Peng Yunjiao Yang Jiaxin Zhou Di Wu Zhichun Liu Xiaofeng Zeng Fengchun Zhang Wenjie Zheng Yan Zhao |
author_sort |
Dong Yan |
title |
The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease |
title_short |
The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease |
title_full |
The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease |
title_fullStr |
The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease |
title_full_unstemmed |
The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s Disease |
title_sort |
clinical features and risk factors of parenchymal neuro-behcet’s disease |
publisher |
Hindawi Limited |
series |
Journal of Immunology Research |
issn |
2314-8861 2314-7156 |
publishDate |
2019-01-01 |
description |
To investigate the clinical features of parenchymal neuro-Behcet’s disease (p-NBD), we retrospectively reviewed the medical records of 1009 BD patients admitted to Peking Union Medical College Hospital from 2000 to 2016. Forty-two patients (25 males and 17 females) with p-NBD and eighty-four age- and sex-matched BD patients without neurological involvement who were served as controls were enrolled. Neurological onset was concomitant with the onset of BD in six cases (14.3%). Pyramidal signs (50.0%) and headache (33.3%) were the most common manifestations. On MRI, the lesions were mainly in the midline structures and hyperintense in the T2-weighted image. The most common lesion was the brainstem (54.8%). Spinal cord involvement was observed in five cases, four of which with cervical cord involvement. Multifocal lesions were observed in 13 patients. Ocular involvement was more prevalent in p-NBD (35.7%) (P=0.041, OR=2.36, 95% CI=1.03-5.44) compared with controls. All patients received corticosteroids and immunosuppressants, mainly cyclophosphamide (39/42). Six patients with severe/refractory condition received biological agents and achieved response measured by decreased Rankin score (P=0.002). With a median follow-up of 28 months, 22 patients (61.1%) achieved clinical improvements, while 10 (27.8%) relapsed and 4 died (mortality rate 11.1%). p-NBD is a rare yet disabling and life-threatening complication of BD. Ocular involvement is a risk factor for p-NBD. Promptly aggressive treatment is essential for improving prognosis, and biological agents might be a promising approach for severe/refractory p-NBD. |
url |
http://dx.doi.org/10.1155/2019/7371458 |
work_keys_str_mv |
AT dongyan theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT jinjingliu theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yuehuazhang theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT weiyuan theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yanxu theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT jingshi theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT chaoranli theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yiningwang theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT linyipeng theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yunjiaoyang theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT jiaxinzhou theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT diwu theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT zhichunliu theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT xiaofengzeng theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT fengchunzhang theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT wenjiezheng theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yanzhao theclinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT dongyan clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT jinjingliu clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yuehuazhang clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT weiyuan clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yanxu clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT jingshi clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT chaoranli clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yiningwang clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT linyipeng clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yunjiaoyang clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT jiaxinzhou clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT diwu clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT zhichunliu clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT xiaofengzeng clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT fengchunzhang clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT wenjiezheng clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease AT yanzhao clinicalfeaturesandriskfactorsofparenchymalneurobehcetsdisease |
_version_ |
1724932708645208064 |
spelling |
doaj-4f69d2fa4a57407f83c3777bf4f0b8772020-11-25T02:06:40ZengHindawi LimitedJournal of Immunology Research2314-88612314-71562019-01-01201910.1155/2019/73714587371458The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet’s DiseaseDong Yan0JinJing Liu1Yuehua Zhang2Wei Yuan3Yan Xu4Jing Shi5Chaoran Li6Yining Wang7Linyi Peng8Yunjiao Yang9Jiaxin Zhou10Di Wu11Zhichun Liu12Xiaofeng Zeng13Fengchun Zhang14Wenjie Zheng15Yan Zhao16Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Oncology and Immunology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, ChinaDepartment of Rheumatology, Kailuan General Hospital, Hebei United University, Tangshan 063000, ChinaDepartment of Neurology, Peking Union Medical College Hospital, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Radiology, Peking Union Medical College Hospital, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, the Ministry of Education Key Laboratory, Beijing 100730, ChinaTo investigate the clinical features of parenchymal neuro-Behcet’s disease (p-NBD), we retrospectively reviewed the medical records of 1009 BD patients admitted to Peking Union Medical College Hospital from 2000 to 2016. Forty-two patients (25 males and 17 females) with p-NBD and eighty-four age- and sex-matched BD patients without neurological involvement who were served as controls were enrolled. Neurological onset was concomitant with the onset of BD in six cases (14.3%). Pyramidal signs (50.0%) and headache (33.3%) were the most common manifestations. On MRI, the lesions were mainly in the midline structures and hyperintense in the T2-weighted image. The most common lesion was the brainstem (54.8%). Spinal cord involvement was observed in five cases, four of which with cervical cord involvement. Multifocal lesions were observed in 13 patients. Ocular involvement was more prevalent in p-NBD (35.7%) (P=0.041, OR=2.36, 95% CI=1.03-5.44) compared with controls. All patients received corticosteroids and immunosuppressants, mainly cyclophosphamide (39/42). Six patients with severe/refractory condition received biological agents and achieved response measured by decreased Rankin score (P=0.002). With a median follow-up of 28 months, 22 patients (61.1%) achieved clinical improvements, while 10 (27.8%) relapsed and 4 died (mortality rate 11.1%). p-NBD is a rare yet disabling and life-threatening complication of BD. Ocular involvement is a risk factor for p-NBD. Promptly aggressive treatment is essential for improving prognosis, and biological agents might be a promising approach for severe/refractory p-NBD.http://dx.doi.org/10.1155/2019/7371458 |